James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Netflix Stock Cools Down, But It Still Dominates the Space

Netflix stock stumbled in Thursday's after-hours action, as investors were reminded the company can't grow in the future the way it has in the past.

3 Big Stock Charts for Friday: General Electric, Nike and Wynn Resorts

Stock charts of NKE, GE and WYNN are poised to close out the week on the verge or major moves. Here's what to watch.

Cannabis-Infused Drinks Are a Slow Burn for NBEV Stock

NBEV stock hasn't raced higher like pot stocks have following recent cannabis-based news, but New Age Beverages is still well-positioned.

3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group

Stock charts of FISV, PFE and PNC are run through the technical trading wringer, and come out as your top prospects.

Walgreens, Already Late to the Party, Arrives Empty-Handed

Walgreens stock was up on the news about its Microsoft partnership, but a closer look reveals this isn't the game-changer the pharmacy needs.